How to switch from Mounjaro to Wegovy WITHOUT risking weight gain, reveals top GP – as ‘King Kong’ jab is set to TRIPLE in price

A leading GP, popular Jab Mounjaro’s prices are set to rise, so that patients will be safely passing between weight loss drugs.

GP and Independent Pharmacy Senior Clinical Advisor Donald Grant warned that the transition under medical control to limit serious side effects and weight gain is ‘very important’.

His statement, one of the largest weight loss treatments in the UK, Cheqep, opponent therapy Wegovy sales recently looking for alternatives in patients increased by more than 500 percent.

GP and Independent Pharmacy Senior Clinical Advisor Donald Grant said: ‘When people think of changing Mounjaro potentially for Wegovy, it is important to understand the safe ways of the transition between these two treatments.

‘This can limit hard side effects and avoid progress from the plateau.’

“It is very important that people in these treatments maintain open and honest interviews that can give special advice to medical past and previous doses with prescription clinicians or GPs.

You cannot switch directly between ‘Mounjaro and Wegovy for’ mg ‘for mg’ because they are different drugs with different powers.

‘Instead, a medical expert will take a dose conversion approach and decide to move, they will support you in this way.’

At the beginning of this month, Eli Lilly confirmed that the price of weight loss Jab Mounjaro, which broke box office records, would rise upright for British patients as of September 1.

The drug, which is prescribed to approximately 90 percent of people in the UK using weight loss injections, increased the highest dose cost of 15 mg and £ 330 per month to £ 330 per month.

Even medium -range doses such as 5 mg pen will rise from approximately £ 92 to £ 180 and an average increase between 126 percent.

Wegovy in the UK private market is usually cheaper. Wegovy’s 2.4 mg maintenance dose is around 250 to 300 per month. At the lower end, wegovy’s anthem is priced around 120 £ to £ 170.

In clinical studies, Mounjaro has shown that any licensed drug provides the largest weight loss, patients were lost to 22.5 percent of body weight of more than 72 weeks at the highest dose.

Compared, Wegovy patients lose up to 17.5 percent at a dose of 2.4 mg in the same period.

Cheqap CEO Toby Nicol said: ‘As Mounjaro price increase spreads, weight loss jab patients vote for their wallets and switch to Wegovy, which is almost effective but has a very low cost.

We got away from the big increase in ‘Wegovy’. It is definitely too early to say, but Wegovy will probably be the most popular weight loss treatment in the UK as patients pass through Mounjaro. ‘

Inspector Pharmacist Aaron Arman stressed the importance of appropriate medical surveillance: ‘Mounjaro and Wegovy are working similarly and proved to be very effective.

‘For patients who cannot meet the price increase, it is possible to switch from Mounjaro to Wegovy, but the dose they can pass will depend on the dose of Mounjaro.’

CEPP’s research says that up to 80 percent of existing Mounjaro users, more than 325,000 are priced from treatment, and will completely change or remove the drug.

Nicol added: ‘Many people will consider switching, and although it is absolutely possible, they know that it is a necessity to do it under the supervision of a reliable pharmacist.

‘Only stopping one treatment and passing to another without needing can serious health results.’

The so -called ‘cowboy’ operators will benefit from the situation.

Nicol warned: ‘Black markets will try to use this situation.

‘Go to any social media site and find cowboy operators in minutes – now sellers, for all intentions and purposes – to get the advantage of mixed patients who cannot be treated but want to continue. As in most things in life, if it is too good to be true, it is probably. ‘